Get Started

SLS

NASD SELLAS Life Sciences Group, Inc.
Oct 23, 2026 · 4:21 PM ET LAST TRADE Market Closed

$11.59 ↑ +0.05 (+0.43%) Trading Up from the previous close of $11.54, and at the day’s high of $11.59

YTD change
+207.42%
vs 20-day SMA
+0.44%
vs 200-day SMA
+38.56%

Price ranges

Previous day
$11.12 $12.37
open $11.91 close $11.35
-$0.56 (-4.70%)
Today
$11.08 $11.59
open $11.29 now $11.59
+$0.30 (+2.66%)
Past week
$9.75 $12.37
from $11.34 now $11.59
+$0.25 (+2.20%)
Past month
$9.75 $12.70
from $11.98 now $11.59
-$0.39 (-3.26%)
This year
$3.23 $15.88
from $3.77 now $11.59
+$7.82 (+207.42%)

Price & Performance

+6.71 (+144.61%) / 6M

$3.58$7.83$12.09$16.34Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 99.9% away from all-time highs of $10,464.00
  • SLS is up 207% since the beginning of the year
  • SLS is up 507% over the past 12 months
  • SLS is down 3% over the past 1 month
  • 30% of all SLS investors are betting against SLS

SLS reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +494.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.05
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $2.0B
Beta 1.68

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$138.4M
Debt$737.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $2.2B

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.28 +2.04%
MRNA Moderna, Inc. $202.63 -17.57%
RVMD Revolution Medicines, Inc. $187.69 -3.39%
ROIV Roivant Sciences Ltd. $37.45 +1.77%
BNTX BioNTech SE Sponsored ADR $89.67 -1.77%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.